HCA HCA Healthcare, Inc.
Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 860730 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.8%
TTM net income YoY6.8%
TTM EPS YoY16.6%
Revenue 3-yr CAGR7.6%
Net income 3-yr CAGR5.8%
Margins
Gross margin—
Operating margin—
Net margin8.6%
FCF margin7.6%
EBITDA margin—
Returns
ROE—
ROA11.0%
ROIC (approx.)—
Asset turnover1.28x
Leverage & solvency
Liabilities / assets107.2%
Debt / equity—
Current ratio0.82x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.65x
Accruals ratio-7.1%
Payout ratio10.1%
Capex / revenue6.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $19.85B | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B |
| SG&A expense | $146.00M | $148.00M | $133.00M | $153.00M | $139.00M | $130.00M | $126.00M | $120.00M |
| Interest expense | $607.00M | $599.00M | $584.00M | $572.00M | $561.00M | $568.00M | $547.00M | $528.00M |
| Pretax income | $2.37B | $2.49B | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B |
| Income tax | $521.00M | $564.00M | $430.00M | $509.00M | $515.00M | $524.00M | $502.00M | $447.00M |
| Net income | $1.58B | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B |
| EPS (basic) | 7.36 | 7.70 | 7.25 | — | 7.05 | 6.91 | 6.52 | — |
| EPS (diluted) | 7.27 | 7.62 | 7.15 | — | 6.96 | 6.83 | 6.45 | — |
| Dividends declared per share | 0.78 | 0.78 | 0.78 | 0.72 | 0.72 | 0.72 | 0.72 | 0.66 |
| Weighted avg. shares (diluted) | 217.21M | 222.83M | 226.65M | — | 236.18M | 241.91M | 249.44M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $908.00M | $1.01B | $940.00M | $1.04B | $997.00M | $939.00M | $1.06B | $1.93B |
| Receivables | $11.51B | $12.28B | $11.32B | $10.87B | $10.43B | $10.46B | $11.09B | $10.75B |
| Inventory | $1.67B | $1.66B | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B |
| Current assets | $16.22B | $17.19B | $16.05B | $15.78B | $15.29B | $15.56B | $16.26B | $16.41B |
| PP&E, net | $32.27B | $31.82B | $31.47B | $31.14B | $30.57B | $30.12B | $29.74B | $29.41B |
| Total assets | $63.45B | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B |
| Current liabilities | $19.78B | $17.31B | $19.26B | $16.35B | $17.90B | $15.94B | $13.63B | $15.18B |
| Short-term debt | $8.09B | $6.26B | $8.53B | $4.89B | $6.11B | $5.10B | $3.52B | $4.70B |
| Long-term debt | $42.40B | $43.45B | $39.49B | $41.60B | $38.40B | $39.38B | $41.06B | $38.33B |
| Total debt | $50.49B | $49.72B | $48.02B | $46.49B | $44.51B | $44.48B | $44.58B | $43.03B |
| Total liabilities | $68.05B | $66.46B | $64.43B | $63.49B | $61.91B | $60.77B | $60.24B | $58.96B |
| Shareholders' equity | -$8.08B | -$6.64B | -$6.30B | -$6.03B | -$5.33B | -$4.39B | -$3.52B | -$2.50B |
| Net debt | $49.59B | $48.70B | $47.08B | $45.45B | $43.51B | $43.54B | $43.52B | $41.10B |
| Shares outstanding | 210.88M | 217.96M | 222.53M | 224.61M | 229.85M | 236.14M | 242.96M | 249.98M |
| Cash flow statement | ||||||||
| Operating cash flow | $4.46B | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B |
| Capital expenditure | $1.36B | $1.23B | $1.12B | $1.49B | $1.29B | $1.18B | $991.00M | $1.28B |
| Free cash flow | $3.10B | $1.10B | $895.00M | $870.00M | $3.13B | $3.03B | $660.00M | $1.27B |
| Investing cash flow | -$1.92B | -$1.56B | -$1.28B | -$1.32B | -$1.39B | -$1.25B | -$1.03B | -$1.35B |
| Financing cash flow | -$2.65B | -$704.00M | -$830.00M | -$999.00M | -$2.97B | -$3.09B | -$1.50B | -$2.16B |
| Depreciation & amortization | $954.00M | $944.00M | $930.00M | $911.00M | $889.00M | $863.00M | $860.00M | $856.00M |
| Stock-based compensation | $133.00M | $85.00M | $86.00M | $100.00M | $104.00M | $99.00M | $98.00M | $85.00M |
| Dividends paid | $165.00M | $171.00M | $183.00M | $162.00M | $166.00M | $171.00M | $180.00M | $165.00M |
| Share buybacks | $2.97B | $2.06B | $1.57B | $2.56B | $2.50B | $2.50B | $2.51B | $1.70B |
Free plan shows the latest 8 periods; Pro shows all 67 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.